跳至主要内容
临床试验/NCT02699255
NCT02699255已完成不适用

A Single-center Observational Study to Examine the Occurrence of Ventricular Arrhythmias After Pulmonary Vein Isolation

Universitätsklinikum Hamburg-Eppendorf1 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
111
试验地点
1
主要终点
Ventricular arrhythmias

研究概览

简要总结

The investigators study aimed to observe the occurrence of new premature ventricular complexes and other ventricular arrhythmias after pulmonary vein isolation.

详细描述

Atrial fibrillation is the most common arrhythmia with a lifetime risk for development of over 20%. Pulmonary vein isolation is now established as therapy of choice for patients with symptomatic atrial fibrillation. It is well known that this interventional therapy inevitably modulates the intracardiac autonomic nervous system. While this ablation might alter atrial electrophysiology beneficially, the impact on ventricular electrophysiology remains unclear.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Paroxysmal atrial fibrillation scheduled to undergo pulmonary vein isolation

排除标准

  • Age < 18 years
  • Persistent atrial fibrillation
  • Life expectancy less than 12 months
  • Acute myocardial infarction, coronary artery bypass graft surgery, open heart surgery, or percutaneous transluminal coronary angioplasty within less than 3 months prior to inclusion
  • Documentation of >30 premature ventricular complexes per hour, salvos or ventricular tachycardias prior to atrial fibrillation ablation

结局指标

主要结局

Ventricular arrhythmias

时间窗: one year

Number of patients with premature ventricular complexes, ventricular tachycardias or ventricular fibrillation.

次要结局

  • Arrhythmia recurrence(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. Christian Meyer

Prof. Dr.

Universitätsklinikum Hamburg-Eppendorf

研究点 (1)

Loading locations...

相似试验